대장암 분자진단 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2029년에는 CAGR 8.1%로 성장할 전망이며, 37억 9,000만 달러로 성장이 예측됩니다. 예측 기간 성장은 인구의 고령화 및 위험 요인의 증가, 게놈 데이터의 임상에 대한 통합, 정밀 의료 접근법의 대두, 암 연구와 공동 연구에 있어서 세계의 대처에 기인할 것으로 보입니다. 예측 기간 주요 동향으로는 조기 발견 바이오마커 중시, 데이터 분석에서 인공지능(AI)의 통합, 순환종양 DNA(CTDNA) 해석 증가, 표적치료용 동반 진단 확대, 면역요법 바이오마커 중시 등이 있습니다.
염증성 장질환(IBD)의 이환율 상승이, 향후의 대장암 분자진단 시장의 성장을 견인할 것으로 예측되고 있습니다. 염증성 장질환(IBD)은 주로 결장과 직장을 침범하는 소화관의 염증으로 특징지어지는 만성 소화관 질환으로 복통, 설사, 체중 감소 등의 증상을 동반합니다. 이러한 질환은 일반적으로 약물 요법, 생활 습관 개선, 때로는 수술에 의해 관리됩니다. 결장직장암(CRC)의 전신요법 결정은 종양의 분자평가에서 얻을 수 있는 결과에 크게 의존하기 때문에 IBD의 이환율 증가는 정확하고 효율적이며 고도의 진단 솔루션에 대한 수요를 높이고 있습니다. 예를 들어 2024년 4월 Crohn's & Colitis UK가 실시한 조사에 따르면 영국에서는 약 50만 명이 염증성 장질환(IBD)을 앓고 있었으며, 이는 기존 추정치의 거의 2배인 것으로 나타났습니다. 따라서 염증성 장질환(IBD)의 이환율 증가는 대장암 분자진단 시장의 성장을 촉진할 것으로 보입니다.
대장암 유병률 상승이 대장암 분자진단 시장의 성장을 견인할 것으로 예측됩니다. 대장암은 결장과 직장을 침범하여 이러한 소화기계 영역에서 세포의 무질서한 증식이 종양 형성으로 이어집니다. 대장암 환자의 급증은 암 검출과 치료에 필수적인 분자 진단 도구의 수요를 높이고 있습니다. 2023년 3월 미국암협회가 강조한 바와 같이 추정 153,020명이 대장암 진단을 받았고 약 52,550명이 사망할 것으로 예측되었습니다. 이 예측에는 50세 미만의 19,550례와 3,750례의 사망이 포함되어 있습니다. 이처럼 대장암 유병률 상승은 대장암 분자진단 시장의 성장을 촉진하는 중요한 요인입니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향 및 전략
제4장 시장-금리, 인플레이션, 지정학, 코로나, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석 및 전략 분석 프레임워크
- 세계의 대장암 분자진단 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인 및 억제요인)
- 최종 이용 산업의 분석
- 세계의 대장암 분자진단 시장 : 성장률 분석
- 세계의 대장암 분자진단 시장 실적 : 규모 및 성장(2019-2024년)
- 세계의 대장암 분자진단 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
- 세계의 대장암 분자진단 전체 시장 규모(TAM)
제6장 시장 세분화
- 세계의 대장암 분자진단 시장 : 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 기기
- 시약 및 키트
- 서비스
- 세계의 대장암 분자진단 시장 : 기술별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 중합효소 연쇄반응(PCR)
- 시퀀싱
- 질량 분석
- 전사에 의한 증폭
- 칩과 마이크로어레이
- 등온 핵산 증폭 기술(INAAT)
- 세계의 대장암 분자진단 시장 : 최종 사용자별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 병원
- 외래수술센터(ASC)
- 진단 실험실
- 가정치료 환경
- 세계의 대장암 분자진단 시장 : 기기별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- PCR 기계
- 시퀀서
- 마이크로어레이
- 세계의 대장암 분자진단 시장 : 시약 및 키트 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- DNA 및 RNA 추출 키트
- 분석 키트
- 시약 팩
- 세계의 대장암 분자진단 시장 : 서비스 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 진단 검사 서비스
- 유전자 검사 서비스
- 컨설팅 서비스
제7장 지역별 및국가별 분석
- 세계의 대장암 분자진단 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 세계의 대장암 분자진단 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도 및 기업 프로파일
- 대장암 분자진단 시장 :경쟁 구도
- 대장암 분자진단 시장 : 기업 프로파일
- Johnson & Johnson 개요, 제품 및 서비스, 전략 및 재무 분석
- Bayer AG 개요, 제품 및 서비스, 전략 및 재무 분석
- Abbott Laboratories 개요, 제품 및 서비스, 전략 및 재무 분석
- Danaher Corporation 개요, 제품 및 서비스, 전략 및 재무 분석
- Becton Dickinson and Company 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
- Biocartis Group NV
- Agilent Technologies Inc.
- Grifols SA
- Hologic Inc.
- Biomerieux SA
- Quidel Corporation
- Bio-Rad Laboratories Inc.
- Qiagen NV
- Exact Sciences Corporation
- Illumina Inc.
- Cepheid
- Myriad Genetics Inc.
- Guardant Health
- Luminex Corporation
- GenMark Diagnostics
제32장 세계 시장 경쟁 벤치마킹 및 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문 및 전략
- 대장암 분자진단 시장 : 새로운 기회를 제공하는 국가(2029년)
- 대장암 분자진단 시장 : 새로운 기회를 제공하는 부문(2029년)
- 대장암 분자진단 시장 : 성장 전략(2029년)
제36장 부록
AJY
Colorectal cancer, also known as colon cancer or rectal cancer, is a malignant tumor that forms in the colon (large intestine) or rectum (final part of the digestive tract before the anus). It originates from the inner lining of these gastrointestinal segments. Colorectal cancer molecular diagnostics involve advanced techniques to identify specific genetic mutations, alterations, and biomarkers crucial for understanding the development, progression, and treatment response of colorectal cancer.
The primary components of colorectal cancer molecular diagnostics include instruments, reagents, kits, and services. Instruments are specialized tools or devices designed for analyzing and detecting molecular changes, such as genetic mutations, variations in gene expression, or specific biomolecules, within biological samples from patients with colorectal cancer. Molecular diagnostic solutions employ technologies such as polymerase chain reaction (PCR), sequencing, mass spectrometry, transcription-mediated amplification, chips and microarrays, and isothermal nucleic acid amplification technology (INAAT). These diagnostics are utilized by various end-users, including hospitals, ambulatory surgical centers, diagnostic laboratories, and homecare settings.
The colorectal cancer molecular diagnostics market research report is one of a series of new reports from The Business Research Company that provides colorectal cancer molecular diagnostics market statistics, including colorectal cancer molecular diagnostics industry global market size, regional shares, competitors with a colorectal cancer molecular diagnostics market share, detailed colorectal cancer molecular diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the colorectal cancer molecular diagnostics industry. This colorectal cancer molecular diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The colorectal cancer molecular diagnostics market size has grown strongly in recent years. It will grow from $2.56 billion in 2024 to $2.77 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to increasing incidence of colorectal cancer, growing awareness, and screening initiatives, rising emphasis on personalized medicine, government initiatives for cancer control.
The colorectal cancer molecular diagnostics market size is expected to see strong growth in the next few years. It will grow to $3.79 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to aging population and increased risk factors, integration of genomic data into clinical practice, rise in precision medicine approaches, global efforts in cancer research and collaboration. Major trends in the forecast period include increasing emphasis on early detection biomarkers, integration of artificial intelligence (ai) in data analysis, rise of circulating tumor DNA (CTDNA) analysis, expansion of companion diagnostics for targeted therapies, focus on immunotherapy biomarkers.
The rising incidence of inflammatory bowel diseases (IBD) is projected to drive the growth of the colorectal cancer molecular diagnostic market in the future. Inflammatory bowel diseases (IBD) are chronic gastrointestinal disorders marked by inflammation of the digestive tract, primarily affecting the colon and rectum, and are associated with symptoms such as abdominal pain, diarrhea, and weight loss. These conditions are typically managed through medications, lifestyle modifications, and sometimes surgery. The growing incidence of IBD is increasing the demand for accurate, efficient, and advanced diagnostic solutions, which are crucial since determining systemic therapy for colorectal cancer (CRC) largely depends on the results obtained from molecular assessments of the tumor. For instance, in April 2024, research conducted by Crohn's & Colitis UK revealed that approximately 500,000 people in the UK are living with inflammatory bowel disease (IBD), nearly double previous estimates. Therefore, the rising incidences of inflammatory bowel diseases (IBD) will propel the growth of the colorectal cancer molecular diagnostic market.
The escalating prevalence of colorectal cancer is forecasted to drive the growth of the colorectal cancer molecular diagnostics market. Colorectal cancer affects the colon or rectum, resulting from the uncontrolled growth of cells in these digestive system areas, leading to tumor formation. The upsurge in colorectal cancer cases intensifies the demand for molecular diagnostic tools crucial in cancer detection and treatment. As highlighted by the American Cancer Society in March 2023, an estimated 153,020 individuals are anticipated to receive a colorectal cancer diagnosis, with around 52,550 projected deaths. This forecast includes 19,550 cases and 3,750 deaths among individuals under 50 years old. Thus, the rising prevalence of colorectal cancer is a key driver fueling growth within the colorectal cancer molecular diagnostics market.
Major companies are dedicated to pioneering innovative solutions in molecular diagnostics and personalized medicine, exemplified by the introduction of the Shield Blood Test approach for early-stage colorectal cancer detection. Guardant Health, a prominent US-based biotechnology company specializing in oncology molecular diagnostic products, launched the Shield Blood Test in May 2022. This groundbreaking blood test offers a convenient screening method involving a simple blood draw, addressing challenges associated with patient reluctance to undergo screening. The test demonstrated a sensitivity of 91% for detecting colorectal cancer and 20% for identifying advanced adenomas, with a specificity of 92%. Leveraging data from diverse cohorts comprising over 2,000 individuals with colorectal cancer, 357 with advanced adenoma, and 3,757 healthy subjects, the Shield test identifies early signals of colorectal cancer in the blood.
In July 2023, New Day Diagnostics LLC, a reputable US-based medical equipment manufacturing company, completed the acquisition of Epigenomics AG assets for an undisclosed sum. This strategic acquisition broadens New Day Diagnostics' portfolio in the realm of cancer diagnostics by acquiring intellectual property from Epigenomics AG. Notably, the acquisition includes Epi ProColon, an innovative screening technology specifically designed for the non-invasive detection of colorectal cancer. Epigenomics AG, headquartered in Germany, is a recognized player in the field of colorectal cancer molecular diagnostics, emphasizing the development of cutting-edge technologies for cancer detection.
Major companies operating in the colorectal cancer molecular diagnostics market report are Johnson & Johnson, Bayer AG, Abbott Laboratories, Danaher Corporation, Becton Dickinson and Company, Biocartis Group NV, Agilent Technologies Inc., Grifols S.A, Hologic Inc., Biomerieux SA, Quidel Corporation, Bio-Rad Laboratories Inc., Qiagen N.V., Exact Sciences Corporation, Illumina Inc., Cepheid, Myriad Genetics Inc., Guardant Health, Luminex Corporation, GenMark Diagnostics, Amoy Diagnostics Co. Ltd., MDxHealth Inc., HTG Molecular Diagnostics Inc., GenPath Diagnostics, geneOmbio Technologies Pvt.
North America was the largest region in the colorectal cancer molecular diagnostics market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the colorectal cancer molecular diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the colorectal cancer molecular diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The colorectal cancer molecular diagnostics market consists of revenues earned by entities by providing diagnostic genetic mutation analysis, biomarker profiling, and epigenetic analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The colorectal cancer molecular diagnostics market consists of sales of molecular diagnostic biochips, liquid biopsy kits, and bioinformatics software. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Colorectal Cancer Molecular Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on colorectal cancer molecular diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for colorectal cancer molecular diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The colorectal cancer molecular diagnostics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Type: Instruments; Reagents And Kits; Services
- 2) By Technology: Polymerase Chain Reaction (PCR); Sequencing; Mass Spectrometry; Transcription Mediated Amplification; Chips And Microarrays; Isothermal Nucleic Acid Amplification Technology (INAAT)
- 3) By End Users: Hospitals; Ambulatory Surgical Centers; Diagnostic Laboratories; Homecare Settings
- Subsegments:
- 1) By Instruments: PCR Machines; Sequencers; Microarrays
- 2) By Reagents And Kits: DNA Or RNA Extraction Kits; Assay Kits; Reagent Packs
- 3) By Services: Diagnostic Testing Services; Genetic Testing Services; Consultation Services
- Companies Mentioned: Johnson & Johnson; Bayer AG; Abbott Laboratories; Danaher Corporation; Becton Dickinson and Company
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Colorectal Cancer Molecular Diagnostics Market Characteristics
3. Colorectal Cancer Molecular Diagnostics Market Trends And Strategies
4. Colorectal Cancer Molecular Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Colorectal Cancer Molecular Diagnostics Growth Analysis And Strategic Analysis Framework
- 5.1. Global Colorectal Cancer Molecular Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Colorectal Cancer Molecular Diagnostics Market Growth Rate Analysis
- 5.4. Global Colorectal Cancer Molecular Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Colorectal Cancer Molecular Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Colorectal Cancer Molecular Diagnostics Total Addressable Market (TAM)
6. Colorectal Cancer Molecular Diagnostics Market Segmentation
- 6.1. Global Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Instruments
- Reagents And Kits
- Services
- 6.2. Global Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Polymerase Chain Reaction (PCR)
- Sequencing
- Mass Spectrometry
- Transcription Mediated Amplification
- Chips And Microarrays
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- 6.3. Global Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Ambulatory Surgical Centers
- Diagnostic Laboratories
- Homecare Settings
- 6.4. Global Colorectal Cancer Molecular Diagnostics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- PCR Machines
- Sequencers
- Microarrays
- 6.5. Global Colorectal Cancer Molecular Diagnostics Market, Sub-Segmentation Of Reagents And Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- DNA Or RNA Extraction Kits
- Assay Kits
- Reagent Packs
- 6.6. Global Colorectal Cancer Molecular Diagnostics Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Diagnostic Testing Services
- Genetic Testing Services
- Consultation Services
7. Colorectal Cancer Molecular Diagnostics Market Regional And Country Analysis
- 7.1. Global Colorectal Cancer Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Colorectal Cancer Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market
- 8.1. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Colorectal Cancer Molecular Diagnostics Market
- 9.1. China Colorectal Cancer Molecular Diagnostics Market Overview
- 9.2. China Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Colorectal Cancer Molecular Diagnostics Market
- 10.1. India Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Colorectal Cancer Molecular Diagnostics Market
- 11.1. Japan Colorectal Cancer Molecular Diagnostics Market Overview
- 11.2. Japan Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Colorectal Cancer Molecular Diagnostics Market
- 12.1. Australia Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Colorectal Cancer Molecular Diagnostics Market
- 13.1. Indonesia Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Colorectal Cancer Molecular Diagnostics Market
- 14.1. South Korea Colorectal Cancer Molecular Diagnostics Market Overview
- 14.2. South Korea Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Colorectal Cancer Molecular Diagnostics Market
- 15.1. Western Europe Colorectal Cancer Molecular Diagnostics Market Overview
- 15.2. Western Europe Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Colorectal Cancer Molecular Diagnostics Market
- 16.1. UK Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Colorectal Cancer Molecular Diagnostics Market
- 17.1. Germany Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Colorectal Cancer Molecular Diagnostics Market
- 18.1. France Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Colorectal Cancer Molecular Diagnostics Market
- 19.1. Italy Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Colorectal Cancer Molecular Diagnostics Market
- 20.1. Spain Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Colorectal Cancer Molecular Diagnostics Market
- 21.1. Eastern Europe Colorectal Cancer Molecular Diagnostics Market Overview
- 21.2. Eastern Europe Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Colorectal Cancer Molecular Diagnostics Market
- 22.1. Russia Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Colorectal Cancer Molecular Diagnostics Market
- 23.1. North America Colorectal Cancer Molecular Diagnostics Market Overview
- 23.2. North America Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Colorectal Cancer Molecular Diagnostics Market
- 24.1. USA Colorectal Cancer Molecular Diagnostics Market Overview
- 24.2. USA Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Colorectal Cancer Molecular Diagnostics Market
- 25.1. Canada Colorectal Cancer Molecular Diagnostics Market Overview
- 25.2. Canada Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Colorectal Cancer Molecular Diagnostics Market
- 26.1. South America Colorectal Cancer Molecular Diagnostics Market Overview
- 26.2. South America Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Colorectal Cancer Molecular Diagnostics Market
- 27.1. Brazil Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Colorectal Cancer Molecular Diagnostics Market
- 28.1. Middle East Colorectal Cancer Molecular Diagnostics Market Overview
- 28.2. Middle East Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Colorectal Cancer Molecular Diagnostics Market
- 29.1. Africa Colorectal Cancer Molecular Diagnostics Market Overview
- 29.2. Africa Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Colorectal Cancer Molecular Diagnostics Market Competitive Landscape And Company Profiles
- 30.1. Colorectal Cancer Molecular Diagnostics Market Competitive Landscape
- 30.2. Colorectal Cancer Molecular Diagnostics Market Company Profiles
- 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
31. Colorectal Cancer Molecular Diagnostics Market Other Major And Innovative Companies
- 31.1. Biocartis Group NV
- 31.2. Agilent Technologies Inc.
- 31.3. Grifols S.A
- 31.4. Hologic Inc.
- 31.5. Biomerieux SA
- 31.6. Quidel Corporation
- 31.7. Bio-Rad Laboratories Inc.
- 31.8. Qiagen N.V.
- 31.9. Exact Sciences Corporation
- 31.10. Illumina Inc.
- 31.11. Cepheid
- 31.12. Myriad Genetics Inc.
- 31.13. Guardant Health
- 31.14. Luminex Corporation
- 31.15. GenMark Diagnostics
32. Global Colorectal Cancer Molecular Diagnostics Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Colorectal Cancer Molecular Diagnostics Market
34. Recent Developments In The Colorectal Cancer Molecular Diagnostics Market
35. Colorectal Cancer Molecular Diagnostics Market High Potential Countries, Segments and Strategies
- 35.1 Colorectal Cancer Molecular Diagnostics Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Colorectal Cancer Molecular Diagnostics Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Colorectal Cancer Molecular Diagnostics Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
